5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer.
Preston MA, Wilson KM, Markt SC, Ge R, Morash C, Stampfer MJ, Loda M, Giovannucci E, Mucci LA, Olumi AF.
Preston MA, et al. Among authors: giovannucci e.
JAMA Intern Med. 2014 Aug;174(8):1301-7. doi: 10.1001/jamainternmed.2014.1600.
JAMA Intern Med. 2014.
PMID: 24887392
Free PMC article.